Skip to Main Content

Paper Details

Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index.
Target Oncol
7
2022
Author NameAffiliation
Fiona BlackhallThe Christie NHS Foundation Trust
Fiona BlackhallUniversity of Manchester
  • 1 - 2

Datasets

Release 1.2